Paid Clinical Trials Yuma

Discover 22 paid clinical trials in Yuma, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 22

LasmiditanA 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Imperial CA, San Diego CA, Phoenix AZ, Scottsdale AZshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

V940 vs. PembrolizumabA Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Yuma AZ, Orange CA, Los Angeles CA, Colorado Springs COshow 38 more

Code:

NCT06077760

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

V940

Pembrolizumab

Placebo

Fianlimab & CemiplimabA Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Yuma AZ, Rancho Mirage CA, Redlands CA, Tucson AZshow 22 more

Code:

NCT05785767

Conditions

Advanced Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

fianlimab

cemiplimab

Placebo

NMRA-335140-501Study to Assess the Safety and Effectiveness of NMRA-335140-501

Recruiting

PHASE3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Imperial CA, Temecula CA, Phoenix AZ, Oceanside CAshow 83 more

Code:

NCT06029439

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA-335140

DazodalibepA Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Recruiting

PHASE3

Sponsor:

Amgen

Location:

Glendale AZ, La Jolla CA, Phoenix AZ, Chandler AZshow 38 more

Code:

NCT06104124

Conditions

Sjogren's Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dazodalibep

Placebo

ALTO-100ALTO-100 in Bipolar Disorder with Depression (BD-D)

Recruiting

PHASE2

Sponsor:

Alto Neuroscience

Location:

Yuma AZ, Imperial CA, Phoenix AZ, Oceanside CAshow 11 more

Code:

NCT06656416

Conditions

Bipolar Disorder I or II with a Major Depressive Episode

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

ALTO-100

Placebo

LasmiditanA Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Imperial CA, San Diego CA, Phoenix AZ, Scottsdale AZshow 73 more

Code:

NCT04396236

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

Placebo

Telisotuzumab Vedotin vs. DocetaxelA Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Yuma AZ, Rancho Mirage CA, Phoenix AZ, Chandler AZshow 47 more

Code:

NCT04928846

Conditions

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telisotuzumab Vedotin

Docetaxel

ENX-102ENCALM: a Study of ENX-102 As a Monotherapy Treatment in Patients with Generalized Anxiety Disorder

Recruiting

PHASE2

Sponsor:

Engrail Therapeutics INC

Location:

Imperial CA, Phoenix AZ, Oceanside CA, Redlands CAshow 27 more

Code:

NCT05749055

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

ENX-102

Placebo

SP-624A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Recruiting

PHASE2

Sponsor:

Sirtsei Pharmaceuticals, Inc.

Location:

Imperial CA, Lemon Grove CA, Phoenix AZ, Oceanside CAshow 40 more

Code:

NCT06254612

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SP-624

Placebo